19-50790456-CCTG-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The ENST00000270593.2(ACP4):c.58_60del(p.Leu20del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00223 in 1,523,522 control chromosomes in the GnomAD database, including 31 homozygotes. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0074 ( 19 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 12 hom. )
Consequence
ACP4
ENST00000270593.2 inframe_deletion
ENST00000270593.2 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.16
Genes affected
ACP4 (HGNC:14376): (acid phosphatase 4) Acid phosphatases are enzymes capable of hydrolyzing orthophosphoric acid esters in an acid medium. This gene is up-regulated by androgens and is down-regulated by estrogens in the prostate cancer cell line. This gene exhibits a lower level of expression in testicular cancer tissues than in normal tissues. The protein encoded by this gene has structural similarity to prostatic and lysosomal acid phosphatases. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 19-50790456-CCTG-C is Benign according to our data. Variant chr19-50790456-CCTG-C is described in ClinVar as [Benign]. Clinvar id is 3059630.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00737 (1119/151886) while in subpopulation AFR AF= 0.026 (1079/41470). AF 95% confidence interval is 0.0247. There are 19 homozygotes in gnomad4. There are 508 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACP4 | NM_033068.3 | c.58_60del | p.Leu20del | inframe_deletion | 1/11 | ENST00000270593.2 | NP_149059.1 | |
LOC105372439 | XR_936026.3 | n.435-744_435-742del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACP4 | ENST00000270593.2 | c.58_60del | p.Leu20del | inframe_deletion | 1/11 | 1 | NM_033068.3 | ENSP00000270593 | P1 | |
SMIM47 | ENST00000636757.1 | c.-59-744_-59-742del | intron_variant | 5 | ENSP00000489695 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00737 AC: 1119AN: 151772Hom.: 19 Cov.: 32
GnomAD3 genomes
AF:
AC:
1119
AN:
151772
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00166 AC: 2282AN: 1371636Hom.: 12 AF XY: 0.00176 AC XY: 1195AN XY: 677936
GnomAD4 exome
AF:
AC:
2282
AN:
1371636
Hom.:
AF XY:
AC XY:
1195
AN XY:
677936
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00737 AC: 1119AN: 151886Hom.: 19 Cov.: 32 AF XY: 0.00684 AC XY: 508AN XY: 74224
GnomAD4 genome
AF:
AC:
1119
AN:
151886
Hom.:
Cov.:
32
AF XY:
AC XY:
508
AN XY:
74224
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ACP4-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at